benign prostatic hyperplasia
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with BPH who have symptoms of frequent urination and dysuria, diagnosed by digital rectal examination, B-ultrasound, and uroflowmetry. 2. IPSS>=13 and/or QOL>=3 points. 3. Prostate volume > 25ml. 4. The maximum urine flow rate is less than 15ml/s. 5. Residual urine volume 50 years. 7. The patients voluntarily participated and signed the informed consent. 8. PSA4ng/ml, but exclude patients with prostate cancer. 9. In line with the dialectical standard of TCM spleen-kidney qi deficiency and phlegm stasis syndrome.
Exclusion criteria
Exclusion criteria: 1. With other diseases that cause urination disorders, such as prostate cancer. 2. The patient or his authorizer is unwilling to comply with the study protocol. 3. Upper urinary tract hydrops, bladder stones, repeated hematuria, urinary tract infections caused by benign prostatic hyperplasia. 4. Patients with benign prostatic hyperplasia who have failed invasive treatment and who have a history of pelvic surgery or injury. 5. Patients with severe diabetes, hypertension, cardiovascular and cerebrovascular diseases. 6. Patients with major organ dysfunction, such as liver and kidney insufficiency. 7. Psychopaths. 8. Those with allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prostatic hyperplasia I-PSS score;Maximum urinary flow rate;QOL Quality of life score;Average urinary flow rate;Score of deficiency in spleen and kidney and phlegm stasis syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prostate volume;Chronic prostatitis symptom score;Residual urine volume; | — |
Countries
China
Contacts
Second Hospital of Tianjin Medical University